Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Nov 12, 2020Ramp up of U.S. commercial sales and marketing infrastructure resulting in B2B2C pipeline growthDarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the third quarter 2020 and provided a corporate and commercial update....
-
Nov 4, 2020Earnings Discussion and Business Update Scheduled for 9:00 am Eastern Time
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced it would release its second quarter ended September 30, 2020,...
- Oct 13, 2020DarioHealth selected after careful vetting of numerous digital therapeutics providers.
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced that Vitality Group has chosen the company's digital therapeutics solutions for inclusion in...
- Sep 21, 2020Agreement extends DarioHealth's reach into HMC's vast multi-employer welfare fund and employer client base through which HMC is currently managing more than one million members
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, and HMC HealthWorks, a 40-year veteran in healthcare management with clinically-integrated models of care...
-
Sep 16, 202040+ year healthcare career includes serving as Company Group Chairman at LifeScan, Inc., a multi-billion-dollar diabetes franchise previously owned by Johnson & Johnson (JNJ)
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announces that Eric Milledge has joined DarioHealth as Chairman of the company's newly-established...
-
Aug 13, 2020Observational study results demonstrate improved blood pressure and glycemic control for patients suffering from hypertensive blood pressure and diabetes who used the Dario platform
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that an emerging science industry poster has been accepted for presentation at the virtual...
- Aug 12, 2020Advanced discussions with health plans and self-insured employers furthering our transformation to a B2B2C digital therapeutics leader
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the second quarter 2020 and provided a corporate and commercial update....
- Aug 7, 2020Earnings Discussion and Business Update Scheduled for 9:00 am Eastern Time
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced it will release its second quarter ended June 30, 2020 financial...
-
Jul 31, 2020
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it closed a private placement transaction with accredited investors, including...
-
Jul 20, 2020DarioHealth Enters UK Remote Patient Monitoring (RPM) Market Through Agreement with Williams MedicalAgreement makes the DarioHealth RPM solution available to chronic care patients at general practices across the UK and Ireland
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced that the company has entered into a new strategic partnership with Williams Medical to make the...